Tycoon Group Holdings Limited (HKG:3390)
Hong Kong · Delayed Price · Currency is HKD 0.3150
-0.0250 (-7.35%)
Aug 11, 2025, 11:34 AM HKT
Tycoon Group Holdings Revenue
In the year 2024, Tycoon Group Holdings had annual revenue of 876.04M HKD, down -26.91%. Tycoon Group Holdings had revenue of 441.03M in the half year ending December 31, 2024, a decrease of -26.25%.
Revenue
876.04M
Revenue Growth
-26.91%
P/S Ratio
0.35
Revenue / Employee
3.38M
Employees
260
Market Cap
303.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 876.04M | -322.61M | -26.91% |
| Dec 31, 2023 | 1.20B | 12.46M | 1.05% |
| Dec 31, 2022 | 1.19B | 297.31M | 33.45% |
| Dec 31, 2021 | 888.87M | 382.88M | 75.67% |
| Dec 31, 2020 | 505.99M | -194.76M | -27.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 35.81B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |